NEW YORK (GenomeWeb News) – Plexpress today announced it has partnered with Phalanx Biotech Group to offer a new service allowing researchers to discover, select, and validate biomarkers in a streamlined integrated workflow.
By Justin Petrone
Taiwanese array vendor Phalanx Biotech will launch a microarray for cytogenetics research in the second quarter, entering a market already dominated by Agilent Technologies, Affymetrix, and others.
Phalanx Biotech has updated its OneArray microRNA-expression profiling microarrays.
The update adds 2,406 mature miRNAs and is based on an update to the University of Manchester's miRBase database of miRNAs.
An Affy spokesperson said the firm's interest in the market is an extension of its gene-expression profiling play, and said several "key advantages" over rival tools could enable it to profit in the market, which is poised to grow 25 percent through 2015.